TCW Group Inc. Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

TCW Group Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 296,220 shares of the medical equipment provider's stock after selling 4,188 shares during the period. Intuitive Surgical comprises about 1.3% of TCW Group Inc.'s holdings, making the stock its 18th largest position. TCW Group Inc. owned about 0.08% of Intuitive Surgical worth $145,524,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. State Street Corp lifted its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC grew its position in Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC grew its position in Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after buying an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. raised its holdings in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other news, CFO Jamie Samath sold 108 shares of the company's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,755 shares of company stock worth $26,273,943 in the last quarter. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded up $5.51 during mid-day trading on Wednesday, hitting $543.60. 999,391 shares of the stock traded hands, compared to its average volume of 1,442,025. The firm has a 50 day simple moving average of $518.23 and a two-hundred day simple moving average of $476.59. Intuitive Surgical, Inc. has a twelve month low of $314.38 and a twelve month high of $556.23. The company has a market cap of $193.62 billion, a PE ratio of 87.40, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Wells Fargo & Company raised their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the stock an "overweight" rating in a research note on Wednesday. Robert W. Baird raised their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research note on Thursday, October 17th. Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $550.28.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.